Novel aminopyridine derivatives as mGluR5 antagonists

Details for Australian Patent Application No. 2004218180 (hide)

International Classifications

Event Publications

13 October 2005 PCT application entered the National Phase

PCT publication WO2004/078728 Priority application(s): WO2004/078728

19 July 2007 Change of Name(s) of Applicant(s), Section 104

Addex Pharmaceuticals SA The name of the applicant has been changed to Addex Pharma SA

16 August 2007 Amendment Made

The nature of the amendment is: Amend the invention title to read Novel aminopyridine derivatives as mGluR5 antagonists

12 November 2009 Application Accepted

Published as AU-B-2004218180

11 March 2010 Standard Patent Sealed

29 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.